Samsrita Labs Limited Reports No Deviation in Use of Preferential Issue Proceeds for Q3 FY26

Samsrita Labs Limited has submitted its quarterly compliance statement to stock exchanges, confirming no deviation or variation in the use of proceeds raised through preferential issue for the quarter ended December 31, 2025. The statement was filed in accordance with Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Fund Raising Details

The company successfully raised ₹339.10 lakhs through preferential issue on July 18, 2025. The funds were allocated across four specific objectives to support the company's operational and strategic requirements.

Parameter:	Details
Mode of Fund Raising:	Preferential Issues
Date of Raising Funds:	July 18, 2025
Amount Raised:	₹339.10 lakhs
Report Period:	Quarter ended December 31, 2025
Monitoring Agency:	Not Applicable

Fund Utilization Breakdown

The company has provided a detailed breakdown of fund utilization across the originally planned objectives, demonstrating adherence to the stated purposes without any modifications.

Object:	Original Allocation (₹ lakhs)	Funds Utilized (₹ lakhs)	Status
Working Capital Requirement:	52.10	52.10	Fully Utilized
Investment into New Projects:	132.46	0.00	Not Utilized
Repayment of Unsecured Loans:	88.31	88.31	Fully Utilized
General Corporate Purpose:	66.23	20.83	Partially Utilized

Compliance and Governance

The Audit Committee of Samsrita Labs Limited reviewed the fund utilization statement on February 6, 2026, confirming no deviations from the original allocation plan. The statement indicates that no monitoring agency oversight was required for this preferential issue.

Key compliance highlights include:

No deviation or variation in use of raised funds
No modifications to original objects or allocations
Proper audit committee review and approval
Timely regulatory filing within prescribed timelines

Current Status

The company has fully utilized funds allocated for working capital requirements and loan repayments to promoter directors. Investment in new projects remains unutilized, while general corporate purposes show partial utilization of ₹20.83 lakhs against the allocated ₹66.23 lakhs. The statement was signed by Krishnam Raju Kalidindi, Chairman and Wholetime Director, confirming the accuracy of the reported fund utilization.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-4.97%	-6.11%	-9.58%	-13.90%	+11.93%	-65.79%

Samsrita Labs Limited , a company listed on the BSE and Metropolitan Stock Exchange of India, has reported significant changes in its promoter shareholding. Two promoters of the company have reduced their stakes through off-market transfers.

Key Details of the Transactions

Aspect	Transaction 1	Transaction 2
Promoter Name	Krishnam Raju Kalidindi	Dr. Mohammed Aejaz Habeeb
Number of Shares Sold	2,00,000	7,38,000
Percentage of Total Shareholding	0.88%	3.24%
Mode of Transfer	Off-market	Off-market
Date of Transaction	21-11-2025	12-11-2025

Impact on Promoter Group Holding

The off-market transfers have led to a reduction in the promoter group's collective shareholding in Samsrita Labs Limited.

Shareholding	Before Kalidindi's Transaction	After Kalidindi's Transaction	After Habeeb's Transaction
Promoter Group Holding	26.32%	25.44%	22.20%
Change in Holding	-	-0.88%	-3.24%

These transactions mark shifts in the ownership structure of Samsrita Labs Limited. The reduction in promoter holding could potentially impact the company's governance and decision-making processes.

Investors and market watchers may want to monitor any further disclosures or announcements from the company regarding these changes in shareholding pattern. It's important to note that off-market transfers can occur for various reasons, including restructuring within the promoter group, strategic realignments, or personal financial decisions of the promoters.

Shareholders and potential investors should consider this information in the context of the company's overall performance and market conditions before making any investment decisions.